Services on Demand Journal Article Indicators Related links Share SAMJ: South African Medical Journal On-line version ISSN 2078-5135 Print version ISSN 0256-9574 SAMJ, S
Weeks 17-20: Retatrutide 8 mg weekly + Cagrilintide 0.5 mg weekly (hold steady)
doi: 10.3389/fendo.2022.943408 40 JinD.-X.JiaC.-Y.YangB.WuY.-H.ChenL.LiuR.et al

Less common but more serious side effects that require medical attention include: Pancreatitis (inflammation of the pancreas) characterised by severe, persistent abdominal pain Diabetic retinopathy complications particularly in patients with pre-existing eye disease Hypoglycaemia (low blood sugar) especially when used alongside insulin or sulphonylureas Acute kidney injury often secondary to severe dehydration from vomiting or diarrhoea Gallbladder problems including gallstones and cholecystitis (watch for right upper abdominal pain, fever, or jaundice) Hypersensitivity reactions such as rash, urticaria, or rarely, anaphylaxis Injection site reactions including redness or irritation at the injection site Regarding hearing loss , there is currently no established causal link between Ozempic and auditory impairment in the official product literature or regulatory guidance from the MHRA or EMA (European Medicines Agency)

These compounds increase SIRT1 expression or activity, collectively improving hepatic lipid metabolism, insulin signaling, oxidative stress, autophagy, and inflammatory responses, highlighting their strong multi-target pharmacological potential
No, current FDA prescribing information and clinical trial data do not establish a causal link between tirzepatide and increased blood clot risk